Abstract
Kimura’s Disease (KD) is a benign, relapsing chronic inflammatory condition often seen in young Asian males, manifesting as recurrent swellings in skin and subcutaneous tissues especially in the head and neck region. Eosinophilic granulomatosis with polyangitis (EGPA) is a debilitating multisystem vasculitic condition which causes high morbidity due to cavitating lung lesions, neuropathy and renal impairment. Eosinophilia is common to both conditions. We, herein present a young Asian male with KD who presented with isolated recurrent nasopharyngeal mucosal swelling with eosinophilia. Biopsy of the lesion showed necrotizing vasculitis and eosinophilic granulomata mimicking EGPA. Nevertheless, he did not have any other characteristic systemic features of EGPA. Targeted evaluation through multidisciplinary approach helped secure the diagnosis of KD. KD has a wide range of presentation. The three cardinal histopathologic features in KD are eosinophilic inflammation, vascular proliferation and stromal fibrosis. However, vasculitis, granulomata and variable degree of necrosis can be present as in this case. He responded well to a course of steroids followed by Mycophenolate Mofetil. This minimized iatrogenic morbidity to the patient resulting from use of highly toxic immunomodulators which are not necessary in KD unlike in EGPA.
Keywords
Introduction
Kimura’s disease (KD) is a rare chronic inflammatory disorder which presents as multiple subcutaneous swellings in the head and neck region. It can be variably associated with peripheral eosinophilia, elevated IgE levels and renal involvement. 1 Owing to the benign natural course, keeping under observation or simple surgical or medical therapies often suffice. 2 Eosinophilic Granulomatosis with Polyangiitis (EGPA) on the other hand is a disabling multisystem necrotizing vasculitic disorder requiring aggressive immunomodulatory therapy. It is fatal without timely intervention. 3 We present a case where KD manifested with isolated extra cutaneous swellings of nasopharyngeal mucosa demonstrating eosinophilic granulomatous inflammation on background of chronic sinusitis. This led to a diagnostic dilemma between EGPA and KD. Having been described more than 60 years ago, 4 KD continues to be an ambiguous entity and a challenging diagnosis to make. There is considerable overlap between KD and its close mimicker Angiolymphoid hyperplasia with eosinophilia (ALHE). Several studies have demonstrated the distinguishing features between the two.5,6 However, this is the first report highlighting the potential overlap between KD and EGPA.
Case report
A 30-year-old south Asian man presented with dysphagia for 3 months duration. The dysphagia was attributed to a right sided pharyngeal wall swelling. He gave a previous history of recurrent and disabling sinusitis during the previous 4 years. Two years before, the patient had a swelling involving the right nasal mucosa and nasal bridge after an episode of sinusitis. This nasal swelling had responded to a short course of oral steroids. There had been recurrent swelling of the same nasal mucosal area for the next 14 months leading to nasal blockade accompanied by pansinusitis demonstrated on Contrast-enhanced Computed Tomography (CT). Each episode had responded to multiple antibiotic combinations, nasal sprays, and steroids.
Examination at current presentation demonstrated bilateral cervical lymph-node enlargement. The rest of his examination was unremarkable. Complete evaluation showed mild eosinophilia (800 cells/μL) and ESR of 23 mm/h. Magnetic resonance imaging demonstrated a homogenously enhancing mass lesion (10 x 3.7 x 2.6 mm) extending from the base of the skull along the pharyngeal wall up-to the posterior larynx (as seen in Figure 1) with pansinusitis and regional lymphadenopathy.
(Left-Axial plane; Right- Coronal plane)—MRI images showing the homogenously enhancing right pharyngeal wall mass.
The first biopsy of the lesion was reported as eosinophilic granulomatosis with polyangiitis based on the presence of eosinophilic infiltration, granulomatous inflammation and occasional fibrinoid necrosis. The patient was referred to the current center for specialized rheumatologic management. Antineutrophil cytoplasmic antibodies (cANCA; PR3 ANCA) were not detected. Urine full report did not show proteinuria or active sediment. Although the chest X-ray was normal, high-resolution CT of the chest demonstrated few non-specific ground-glass opacifications in the lung, which were Adeemed insignificant after a multidisciplinary discussion with the radiologist and the chest physician. Serum IgE level was 622 U/mL.
A repeat biopsy was done due to the atypical nature of the presentation, sites of lesions and absence of other organ system involvement. This biopsy showed (showed in Figure 2) vascular hyperplasia with prominent endothelial cells, dense mixed inflammatory infiltrate with eosinophilic predominance and granulomas with eosinophilic necrosis. Special stains with PAS, Grocott, Ziehl–Neelsen and Wade-fite excluded fungal or mycobacterial infective etiology. A clinico-pathological diagnosis of Kimura’s disease was made.
Histology of the nasopharyngeal swelling. H&E stain. (a) Scanner view showing the granulomas and the background inflammatory infiltrate. (b) Perivascular inflammatory infiltrate with eosinophils. (c) Capillaries with plump endothelial cells surrounded by eosinophils. (d) Ill-defined Eosinophilic granuloma. (e) Granuloma with central eosinophilic necrosis.
The patient responded to a second course of oral prednisolone at a dose of 30 mg daily for 3 months tapering down over one month. Eight months later at last follow up he remains in remission while on steroid sparing with Mycophenolate-mofetil.
Discussion
Kimura’s disease
Kimura’s disease (KD), was first described as a pathological entity in 1948 by Kimura et al. 4 It refers to a rare, benign, chronic inflammatory disorder seen commonly in young Asian men manifesting as subcutaneous swellings of the head and neck region. The disease characteristically involves swelling in the skin and subcutaneous tissues including salivary glands, lacrimal glands and lymph nodes. Only a minority of cases as depicted above present with isolated extracutaneous involvement of the oral cavity, palate, larynx or nasopharyngeal mucosa. 7 Peripheral eosinophilia and elevated IgE levels are characteristically seen. The possible pathogenesis from autoimmune or allergic hypersensitivity reaction is postulated partly because of this association. 8 However in cases of isolated oral cavity involvement compared to other extra-oral regions, eosinophilia and IgE response can be modest. 7 The only known organ involvement is renal disease with proteinuria occurring in approximately 16%; some of whom will develop glomerulonephritis in the form of minimal change disease or more aggressive forms like mesangioproliferative glomerulonephritis. 1
Eosinophilic granulomatosis with polyangiitis
On the other hand, EGPA is characterized by the classic triad of asthma, eosinophilia and multisystemic necrotizing vasculitis. Disease onset can be from 7 to 74 years and no gender or ethnic preponderance has been noted. 9 EGPA presents in three distint phases. A first phase characterized by a prodromal illness with asthma, allergic rhinitis or rhinosinusitis for years preceding the more sinister manifestations is typical. This feature was demonstrated in our patient’s presentation as well. The second phase of EGPA is characterized by eosinophilia and target organ damage involving the lungs, heart and gastro-intestinal tract. This patient had mild eosinophilia (800 cells/μl). However in EGPA eosinophilia, as per the American College of Rheumatology diagnostic criteria eosinophilia should be more than 1500 cells/μL. Further the few groundglass opacifications noted in the patient’s HRCT chest were also deemed insignificant by the specialists ruling out lung involvement. The third and most sinister phase in EGPA is the vasculitic phase where mononeuritis multiplex, renal and skin involvement occur. While papular or nodular lesions involving the skin is the typical finding, a case with isolated subconjunctival swelling has been reported.3,10
Discriminating between KD and EGPA
There is considerable histopathologic overlap between the two conditions as well. Eosinophilic infiltration is common to both entities which occurs in the background of dense mixed inflammatory infiltrate. Other two cardinal features in KD are vascular proliferation most prominent in the post capillary venules in case of the lymph-nodes and varying degree of stromal fibrosis. 2 The diagnostic feature in EGPA is the presence of necrotizing vasculitis of small-medium vessels and eosinophilic granulomas. 3 While the presence of granuloma is not characteristic of KD it is well-recognized.11–13 Table 1 shows some of the discrimatory features between EGPA and KD.
Discriminatory features between KD, EGPA and ALHE.
This patient caused a clinical conundrum as he had features which overlapped between KD and EGPA. It was quite important to differentiate between the two because KD is largely a benign and self-limiting entity. Therefore, a meticulous multi-disciplinary approach was required. The modest eosinophilia seen in this patient, the absence of other organ involvement, the histopathological findings, the benign disease course and dramatic response to steroids helped corroborate the diagnosis.
A reasonable differentiation could be made between KD and EGPA based on above findings, but there was a second dilemma making a close call between KD and Angiolymphoid hyperplasia with eosinophilia (ALHE). The latter two share a myriad of common features and it is exceedingly difficult to distinguish such that some authors conclude they may be representing different spectra of the same entity. 5 However there are a few characteristic differentiating features (Refer Table 1). In above case, starting from the male gender and the extracutaneous location of the lesion to the presence of lymphadenopathy, eosinophilia and elevated IgE were more supportive of KD. ALHE lesions typically involve skin and subcutaneous tissue. While lymphadenopathy and eosinophilia maybe seen in a minority of ALHE, elevated IgE levels is exceedingly rare. Further, in the histology, the predominant finding was mixed, eosinophil predominant granulomatous inflammation with some degree of vascular proliferation and fibrosis which was in keeping with KD. Necrotizing vasculitis, granulomata and fibrosis seen in this case are not seen in ALHE. In ALHE florid vascular proliferation with “hobnail” type cells containing abundant cytoplasm is the cardinal finding. 16 Mere presence of plump or cuboidal endothelial cells can be seen in KD.5,6,15
The distinction between the latter two, from the patient’s perspective remained comparatively less critical as the treatment options for KD and ALHE remain largely the same and both have a benign course (Table 1). Therapeutic options for KD include surgical excision, steroids, steroid sparing with cyclosporin/mycophenolate or other cytotoxic therapy and radiotherapy all of which have shown variable response with around one in four cases recurring despite resolution.2,17
A definitive diagnosis addressed the patient’s concern significantly as, lack of a diagnosis over two years was his biggest concern.
Conclusion
KD is a benign relapsing chronic inflammatory condition which is often confused with other inflammatory diseases due to its rarity. We present this case to emphasize the importance of considering conditions like KD in the differentials of atypical presentation of EGPA and related conditions.
Footnotes
Acknowledgements
The Authors would like to acknowledge the members of the multidisciplinary team involving the Radiology, Pathology and medical units who actively participated in securing the diagnosis. We also ackonwledge the timely referral by the ENT surgeon Dr Malkanthi Jayasinghe, which helped avoid unnecessary burden in the form of surgery or strong immunomodulators for the patient.
Declaration of conflicting interests
The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Funding
The author(s) received no financial support for the research, authorship, and/or publication of this article.
Ethics approval
Our institution does not require ethical approval for reporting individual cases or case series.
Informed consent
Written informed consent was obtained from the patient for their anonymized information to be published in this article.
